RLMD
Relmada Therapeutics, Inc. Common Stock
$3.35
4.36%
+0.14
Notify me if price changes either direction
Buy RLMD stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Relmada Therapeutics, Inc. Common Stock (RLMD)
Loading
Key Stats
Market cap.
357.3M
Enterprise value
126.8M
Trailing PE
-2.3172413069626
Forward PE
-7.8658533
PEG Ratio
0.036588020636252
Enterprise to EBITDA
-2.1341977266357
Price to book MRQ
1.6658057
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-06-30
Diluted EPS TTM
-0.9
Total Cash (MRQ)
217.7M
Current ratio (MRQ)
29.517
Operating Cash Flow (TTM)
-45992000
RLMD trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
October 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
